메뉴 건너뛰기




Volumn 27, Issue 2, 2009, Pages 70-74

Bone remodelling and disorders of bone metabolism

Author keywords

bone mineral density; bone remodelling; bone turnover; dual energy X ray absorptiometry; fracture risk; osteoblast; osteoclast; osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN; ETIDRONIC ACID; GROWTH HORMONE; IBANDRONIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; SOMATOMEDIN B; SOMATOMEDIN C; STRONTIUM RANELATE; VITAMIN D; WNT PROTEIN; ZOLEDRONIC ACID;

EID: 60849122587     PISSN: 02639319     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpsur.2008.12.007     Document Type: Review
Times cited : (14)

References (7)
  • 1
    • 84856506439 scopus 로고    scopus 로고
    • The care of fracture fragility patients
    • British Orthopaedic Association The care of fracture fragility patients 2007 British Orthopaedic Association London
    • (2007)
    • British Orthopaedic Association1
  • 2
    • 77950861963 scopus 로고    scopus 로고
    • Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women
    • National Institute for Health and Clinical Excellence Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women HTA 160 2008 Available from: http://www.nice.org.uk
    • (2008) HTA , vol.160
    • National Institute for Health and Clinical Excellence1
  • 3
    • 77950861963 scopus 로고    scopus 로고
    • Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
    • National Institute for Health and Clinical Excellence Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women HTA 161 2008 Available from: http://www.nice.org.uk
    • (2008) HTA , vol.161
    • National Institute for Health and Clinical Excellence1
  • 5
    • 85119769958 scopus 로고    scopus 로고
    • C. Rosen Primer on the metabolic bone diseases and disorders of mineral metabolism 7th edn. 2008 American Society for Bone and Mineral Research Washington DC
    • (2008)
    • Rosen, C.1
  • 6
    • 46549088419 scopus 로고    scopus 로고
    • Assessment of osteoporosis at the primary health care level
    • WHO Assessment of osteoporosis at the primary health care level Summary report of a WHO scientific group. Available from: http://www.who.int/chp/topics/rheumatic/en/index.html 2007
    • (2007)
    • WHO1
  • 7
    • 62149150987 scopus 로고    scopus 로고
    • Fracture risk assessment tool
    • WHO Fracture risk assessment tool Available from: http://www.shef.ac.uk/FRAX 2008
    • (2008)
    • WHO1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.